OTC: AVAI

On February 3, 2026, the Company filed a Certificate
of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to change its corporate name from Avant
Technologies, Inc. to Avaí Bio, Inc. The Company’s trading symbol will remain “AVAI”, and its CUSIP number will
remain 89487B100.

The Company’s name change was announced on FINRA’s
Daily List on February 10, 2026, and became effective at the open of business on February 11, 2026. Following the effective date, the
Company will operate under the name Avai Bio, Inc.

5

On May 23, 2023, the Company
filed an application with the Financial Industry Regulation Authority in order to change the name and trading symbol of the Company. On
July 18, 2023, FINRA announced the Company’s Name Change and Symbol Change, which became effective on July 19, 2023 on the OTC Markets.
The Name Change and Symbol Change do not affect the rights of the Company’s security holders.

The Company’s securities
will continue to be quoted on the OTC Markets. Following the Name Change, the stock certificates, which reflect the former name of the
Company, will continue to be valid. Certificates reflecting the Name Change will be issued in due course as old stock certificates are
tendered for exchange or transfer to the Company’s transfer agent.

On March 6, 2023, the Company
filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to increase
the number of authorized shares of the Company’s common stock from 255,000,000 to 520,000,000 shares (the “Charter Amendment”)
of which 500,000,000 shall be common stock, $0.001 par value per share, and 20,000,000 shall be preferred stock, $0.001 par value per
share.

On June 28, 2019, the Company
acquired Thy News LLC, an owner of a news application with feed from various sources that users can choose and customize. It is available
for free download in Apple AppStore and Google Play Market. Users also will be able to subscribe for additional paid features that extend
the functionality of the original app. At the moment of the first release, the app’s news database consisted of 24,000 processed
news sources, and as of December 31, 2019 this amount increased for more 75,000 processed sources to a total of 99,000 processed sources.
From January 1, 2020 to September 30, 2023 the Company acquired additional 50,000 processed sources. As of December 31, 2025, the users
of the app have an opportunity to choose interesting and relevant news feeds from 149,000 processed sources.

Acquiring Avant! AI Assets

On April 3, 2023, the Company,
entered into an Asset Purchase Agreement (“APA”) along with GBT Tokenize Corp. (“Seller”), which Seller developed
and owns a proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model that is working
based on an innovative, unique concept which learns on its own and constantly enhances its information database with the advantage of
unsupervised learning capabilities (the “System”). At closing, in consideration of acquiring the System, the Company issued
to the Seller 26,000,000 common shares of the Company (the “Shares”). The Shares will be restricted per Rule 144 as promulgated
under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following
closing (the “Lock Up Term”).

Acquiring Instant Fame
Assets

On April 3, 2023, the Company,
entered into an Asset Purchase Agreement (“Treasure APA”) with Treasure Drive Ltd. (“TD”) pursuant to
which the Company agreed to acquire a technology portfolio including certain source codes and pending patent applications which have applications
in a variety of areas including creating systems and methods of facilitating digital rating and secured sales of digital works as well
as core virtual reality platforms known as digital auction systems, rating and secure sales via open bid auctions (“Instant Fame
Assets”). At closing, in consideration of the Instant Fame Assets, the Company issued TD 5,000 shares of Series A Preferred
Stock of the Company with a stated valued at $5,000 per share each (the “Preferred Shares Series A”). The Preferred Shares
Series A may be converted at the option of TD into the Company shares of common stock at a conversion price equal to a 5% discount to
the weighted average closing price during the five (5) days prior of such conversion, and will include a 4.99% beneficial ownership limitation.
The Preferred Shares Series A will have no voting rights and will be entitled to a payment equal to the stated value of the Preferred
Shares Series A in the event of the Company liquidation only.

In addition, the Company
and Elentina Group, LLC (“Elentina”) entered into a Service Agreements in which Elentina, was engaged to provide certain
capital markets services for a flat quarterly fee of $75,000 paid in shares of common stock (the “Elentina Common Stock”).
The Elentina Common Stock to be issued within five days of the first day of quarter during the term (ie January 1, April 1, July 1 and
October 1). The Elentina Common Stock shall be fully earned upon issuance. The number of shares of Elentina Common Stock to be issued
will be determined by dividing the quarterly fee of $75,000 by the Company’s ten (10) day VWAP, which shall at no point be less
than $0.10 per share.

In connection with the offering,
the Company filed a Certificate of Designation to its Articles of Incorporation designating 5,000 shares of its Preferred Stock of Series
A.

6

Acquiring Wired4Health
Assets (Divested)

On April 5, 2024, the Company,
entered into an Asset Purchase Agreement (“W4H APA”) with Wired4Health, Inc. (“Seller” or “W4H”),
pertaining to certain technology assets, providing full-stack software development, database management, data integration, project management
and cloud services resources. The assets being acquired include an agreement and amendments between W4H and Sentry Data Systems/Craneware,
an agreement between W4H and Respec, Inc., agreements between W4H and all of its employees and contractors assigned to Sentry Data Systems/Craneware
and Respec, Inc. customer accounts, Website and Internet Domain Name, Wired4Health.com and all of its content (the “Website“),
and any other rights associated with the Website, including, without limitation, any intellectual property rights, all related domains,
logos, customer lists and agreements, email lists, passwords, usernames and trade names, and all of the related social media accounts,
if any, and any other associated rights, etc. (the “W4H Assets”). At closing, in consideration of acquiring the Assets, the
Company issued Seller an amortizing secured promissory note in the principal amount of $1,200,000 (“Secured Note”) of the
Company’s Series B Convertible Preferred Stock with a stated value of $1,000,000 (the “Preferred Stock”) The Secured
Note is payable by the Company to the Seller in 24 equal monthly installments of principal and interest in the amount of $52,427 on the
first day of each month, beginning on the first day of the month following the closing of the transaction and continuing on the first
day of each consecutive month thereafter until the note is fully paid, but in no case less than two billing cycles of W4H activity. The
Secured Note bears interest of five percent (5%) per annum accrued monthly (0.42% per month on the outstanding principal balance).

The Preferred Stock Series
B has an aggregate stated value of $1,000,000, where the conversion price is equal to the lesser of $1.00 per share each, on a fully diluted
basis, or the volume-weighted average market price (VWAP) of the Company’s common stock as traded on the OTC Markets for the most
recent 30 days prior to deal closure (the “Conversion Price”). Conversion will include a 4.99% beneficial ownership limitation
and a leak out agreement allowing daily sales to not exceed 25% of the total daily volume.

The
Secured Note is secured by the Assets pursuant to the terms of a Security Agreement which, among other things, will authorize the Seller
to file a UCC1 Financing Statement in the State of Nevada. As of the date hereof, the Company
is obligated on approximately $1,200,000 face amount of Secured Notes issued to the Seller. The Secured Note is a debt obligation arising
other than in the ordinary course of business which constitute a direct financial obligation of the Company. Effective May 7, 2024, in
connection with the offering, the Company filed a Certificate of Designation to its Articles of Incorporation designating 1,000,000 shares
of its preferred stock.

On September 9, 2024, the
Company entered into a Cancellation Agreement with Wired4Health, Inc. ("W4H"), a Florida corporation, mutually agreeing to terminate
the Asset Purchase Agreement ("APA") dated April 5, 2024, between the two parties. The APA, originally executed on April 5,
2024, between Avant and Wired4Health, pertained to the acquisition of certain technology assets, including agreements with Sentry Data
Systems/Craneware, Respec, Inc., and other intellectual property rights related to Wired4Health's business operations. In consideration
for the acquisition, Avant had agreed to pay Wired4Health $2,200,000, partially through a secured promissory note and preferred stock.
As of September 9, 2024, both parties agreed to cancel and nullify the original APA under the following terms:

1. Termination of the Original
Agreement: The APA dated April 5, 2024, is terminated in its entirety. Any obligations under the Secured Promissory Note and related Security
Agreement are rendered null and void;

2. Retention of Payments: Any
payments already made by Avant in the ordinary course of business toward the promissory note are retained by Wired4Health, with the remaining
balance of the promissory note deemed void and unenforceable;

3. Release of Claims: Both Avant
and Wired4Health have mutually released and discharged each other from any claims, liabilities, or demands related to the APA. Neither
party shall have any further obligations or claims against the other;

4. Voidance of Instruments: The
Secured Promissory Note and any other instruments associated with the APA are void and have no further legal effect;

5. No Further Obligations: The
parties have agreed that there are no further penalties, remedies, or obligations due to either party following the cancellation of the
AP

Employees Identification

The Company’s Board
Members include: Natalija Tunevic, Secretary; Ivan Lunegov, President & Director; Vitalis Racius, Chief Financial Officer, Director
&Treasurer. Officer which is not director and member of the Board: Chris Winter, Chief Executive Officer.

7

Government Regulation

We will be required to comply with all regulations,
rules, and directives of governmental authorities including the US Securities and Exchange Commission and agencies applicable to our business
in any jurisdiction with which we would conduct activities. We do not believe that governmental regulations will have a material impact
on the way we conduct our business.